Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ACADIA Pharmaceuticals (ACAD
Tag: ACADIA Pharmaceuticals
Needham Releases a Buy Rating on ACADIA Pharmaceuticals (ACAD)
Needham analyst Joseph Stringer assigned a Buy rating to ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price
ACADIA Pharmaceuticals (ACAD) Gets a Hold Rating from Oppenheimer
Oppenheimer analyst Jay Olson assigned a Hold rating to ACADIA Pharmaceuticals (ACAD – Research Report) yesterday and set a price
Oppenheimer Gives a Hold Rating to ACADIA Pharmaceuticals (ACAD)
Oppenheimer analyst Jay Olson assigned a Hold rating to ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price
J.P. Morgan Believes ACADIA Pharmaceuticals (NASDAQ: ACAD) Still Has Room to Grow
J.P. Morgan analyst Cory Kasimov maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) on January 12. The
Analysts’ Top Healthcare Picks: ACADIA Pharmaceuticals (ACAD), Amgen (AMGN)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ACADIA Pharmaceuticals
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD) and IsoRay (NYSE MKT: ISR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ACADIA Pharmaceuticals